WO1997028181A3 - Post-labeling stabilization of radiolabeled proteins and peptides - Google Patents
Post-labeling stabilization of radiolabeled proteins and peptides Download PDFInfo
- Publication number
- WO1997028181A3 WO1997028181A3 PCT/US1997/001695 US9701695W WO9728181A3 WO 1997028181 A3 WO1997028181 A3 WO 1997028181A3 US 9701695 W US9701695 W US 9701695W WO 9728181 A3 WO9728181 A3 WO 9728181A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- peptides
- labeling
- stabilization
- post
- radiolabeled proteins
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1027—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against receptors, cell-surface antigens or cell-surface determinants
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU25264/97A AU2526497A (en) | 1996-02-02 | 1997-02-03 | Post-labeling stabilization of radiolabeled proteins and peptides |
CA002279349A CA2279349C (en) | 1996-02-02 | 1997-02-03 | Ascorbate-stabilized radiopharmaceutical method and composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1102796P | 1996-02-02 | 1996-02-02 | |
US60/011,027 | 1996-02-02 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1997028181A2 WO1997028181A2 (en) | 1997-08-07 |
WO1997028181A3 true WO1997028181A3 (en) | 1997-10-09 |
WO1997028181A9 WO1997028181A9 (en) | 1998-03-05 |
Family
ID=21748542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/001695 WO1997028181A2 (en) | 1996-02-02 | 1997-02-03 | Post-labeling stabilization of radiolabeled proteins and peptides |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2526497A (en) |
CA (1) | CA2279349C (en) |
WO (1) | WO1997028181A2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8992961B2 (en) | 1999-02-08 | 2015-03-31 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US9526763B2 (en) | 2005-02-03 | 2016-12-27 | Intarcia Therapeutics Inc. | Solvent/polymer solutions as suspension vehicles |
US9539200B2 (en) | 2005-02-03 | 2017-01-10 | Intarcia Therapeutics Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7919109B2 (en) | 1999-02-08 | 2011-04-05 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
AU2002218751A1 (en) * | 2000-07-06 | 2002-01-21 | Bristol-Myers Squibb Pharma Company | Stable radiopharmaceutical compositions |
MXPA03007595A (en) * | 2001-02-26 | 2003-12-04 | Bristol Myers Squibb Pharma Co | Ascorbic acid analogs for metalloradiopharmaceuticals. |
US7238338B1 (en) | 2001-06-22 | 2007-07-03 | Triumf | System and method for the large scale labeling of compounds with radiohalogens |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
ES2422864T3 (en) | 2006-08-09 | 2013-09-16 | Intarcia Therapeutics, Inc | Osmotic release systems and piston units |
RU2440097C2 (en) | 2007-04-23 | 2012-01-20 | Интарсия Терапьютикс, Инк. | Method of treating insulin-independent diabetes and obesity, osmotic delivery system and method for making it |
EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
US20100196272A1 (en) * | 2009-01-30 | 2010-08-05 | Neoprobe Corporation | Compositions for radiolabeling diethylenetriaminepentaacetic acid (dtpa)-dextran |
EP3323423B1 (en) | 2009-09-28 | 2020-06-17 | Intarcia Therapeutics, Inc | Rapid establishment and/or termination of substantial steady-state drug delivery |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
EP3302354B1 (en) | 2015-06-03 | 2023-10-04 | i2o Therapeutics, Inc. | Implant placement systems |
CA3016901C (en) | 2016-03-07 | 2023-06-13 | Actinium Pharmaceuticals, Inc. | Stabilized radiolabeled anti-cd45 immunoglobulin compositions |
WO2017200943A1 (en) | 2016-05-16 | 2017-11-23 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
KR20190104039A (en) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Methods Including Continuous Administration of GLP-1 Receptor Agonists and Co-administration of Drugs |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4401646A (en) * | 1981-05-08 | 1983-08-30 | University Patents Inc. | Method and apparatus for purifying materials radiolabeled with technetium-99m |
US4988496A (en) * | 1988-05-31 | 1991-01-29 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
US5308603A (en) * | 1990-03-27 | 1994-05-03 | Thomas Jefferson University | Method to directly radiolabel antibodies for diagnostic imaging and therapy |
US5384113A (en) * | 1991-08-29 | 1995-01-24 | Mallinckrodt Medical, Inc. | Stabilizers to prevent autoradiolysis of radiolabeled peptides and proteins |
US5405597A (en) * | 1991-09-10 | 1995-04-11 | Diatech, Inc. | Technetium-99m labeled somatostatin-derived peptides for imaging |
-
1997
- 1997-02-03 AU AU25264/97A patent/AU2526497A/en not_active Withdrawn
- 1997-02-03 CA CA002279349A patent/CA2279349C/en not_active Expired - Fee Related
- 1997-02-03 WO PCT/US1997/001695 patent/WO1997028181A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4401646A (en) * | 1981-05-08 | 1983-08-30 | University Patents Inc. | Method and apparatus for purifying materials radiolabeled with technetium-99m |
US4988496A (en) * | 1988-05-31 | 1991-01-29 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
US5308603A (en) * | 1990-03-27 | 1994-05-03 | Thomas Jefferson University | Method to directly radiolabel antibodies for diagnostic imaging and therapy |
US5384113A (en) * | 1991-08-29 | 1995-01-24 | Mallinckrodt Medical, Inc. | Stabilizers to prevent autoradiolysis of radiolabeled peptides and proteins |
US5405597A (en) * | 1991-09-10 | 1995-04-11 | Diatech, Inc. | Technetium-99m labeled somatostatin-derived peptides for imaging |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8992961B2 (en) | 1999-02-08 | 2015-03-31 | Intarcia Therapeutics, Inc. | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
US9526763B2 (en) | 2005-02-03 | 2016-12-27 | Intarcia Therapeutics Inc. | Solvent/polymer solutions as suspension vehicles |
US9539200B2 (en) | 2005-02-03 | 2017-01-10 | Intarcia Therapeutics Inc. | Two-piece, internal-channel osmotic delivery system flow modulator |
Also Published As
Publication number | Publication date |
---|---|
AU2526497A (en) | 1997-08-22 |
WO1997028181A2 (en) | 1997-08-07 |
CA2279349A1 (en) | 1997-08-07 |
CA2279349C (en) | 2007-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997028181A3 (en) | Post-labeling stabilization of radiolabeled proteins and peptides | |
UA26855C2 (en) | Pharmaceutical composition regulating hematopoiesis | |
ES2130428T3 (en) | INSULIN CRYSTALS ASP-B28. | |
AU694229B2 (en) | A pharmaceutical preparation comprising glucagon | |
EP0950665A4 (en) | Modified physiologically active proteins and medicinal compositions containing the same | |
DE3855388D1 (en) | 7-piperazinyl or 7-morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents | |
FR2784294B1 (en) | COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING AT LEAST ONE WALL EXTRACT, AT LEAST ONE SCUTELLAR EXTRACT AND AT LEAST ONE SALICYLIC ACID DERIVATIVE | |
IL125800A0 (en) | Thermally stabilized contrast agent | |
EP0586025A3 (en) | Reliable noninvasive measurement of blood gases. | |
HUP0100284A2 (en) | Activated protein c formulations | |
EP0232849A3 (en) | Pyrrolidineamide derivative of acylamino acid, pharmaceutical composition and use | |
HUP0003840A2 (en) | Controlled released medical formulation | |
TW337997B (en) | Pharmaceutical preparation containing plasminogen activators | |
PL366855A1 (en) | Combination preparations of aryl substituted propanolamine derivatives with other active ingredients and the use thereof | |
HUP9802897A3 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
MY136546A (en) | A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component | |
ZA975755B (en) | Useful formulations of acid addition salt drugs. | |
MD980129A (en) | Antiherpetic remedy | |
ATE203903T1 (en) | DELTA-AMINOLEVULIC ACID CONTAINING MEDICINAL PRODUCT | |
WO1999047652A3 (en) | Novel rnase-like protein and its use | |
HUP9802437A3 (en) | 5-pyrazolylbenzoic acid derivatives, herbicidal, desiccant and defoliant compositions containing these compounds as active ingredients, preparation and use of the latest | |
Glowski | Living goddess as incarnate image: the Kumari Cult of Nepal | |
IL83411A (en) | Benzohydroxamic acid derivatives,their preparation and their use as herbicides | |
HU9802896D0 (en) | Optically active piperidinoalkyl-4h-1,2,4-oxadiazine derivative, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WD | Withdrawal of designations after international publication |
Free format text: US |
|
WD | Withdrawal of designations after international publication |
Free format text: US |
|
COP | Corrected version of pamphlet |
Free format text: PAGES 1/10-10/10, DRAWINGS, REPLACED BY NEW PAGES 1/13-13/13; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97527884 Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref document number: 2279349 Country of ref document: CA Ref country code: CA Ref document number: 2279349 Kind code of ref document: A Format of ref document f/p: F |
|
122 | Ep: pct application non-entry in european phase |